MedPath

A Product Performance Evaluation of a Novel Contact Lens for Daily Disposable Use

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Johnson and Johnson 1-Day Acuvue Moist contact lenses
Device: Novel Bausch & Lomb daily disposable contact lenses
Device: Bausch & Lomb SofLens daily disposable contact lenses.
Registration Number
NCT00784641
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

Evaluation of the clinical performance of a novel Bausch \& Lomb daily disposable contact lens when compared to the currently marketed Bausch \& Lomb SofLens® daily disposable contact lenses and the currently marketed Johnson and Johnson 1-Day Acuvue Moist contact lenses when worn by adapted soft contact lens wearers on a daily disposable basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
567
Inclusion Criteria
  • Subjects with VA correctable to 0.3 logMAR (driving vision) or better in each eye.
  • Subjects must have clear central corneas and be free of any anterior segment disorders.
  • Subjects must be myopic and require lens correction in both eyes.
Exclusion Criteria
  • Subjects with any systemic disease affecting ocular health.
  • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Subjects wearing monovision, multifocal or toric contact lenses.
  • Subjects with grade 2 or greater slit lamp findings.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AcuvueJohnson and Johnson 1-Day Acuvue Moist contact lensesJohnson and Johnson 1-Day Acuvue Moist contact lenses
Novel Bausch & Lomb Contact LensNovel Bausch & Lomb daily disposable contact lensesNovel Bausch \& Lomb daily disposable contact lenses
SofLensBausch & Lomb SofLens daily disposable contact lenses.Bausch \& Lomb SofLens daily disposable contact lenses
Primary Outcome Measures
NameTimeMethod
Percentage of Participants With Favorable Responses for the Initial Lens Performance SurveyAt dispensing

The initial lens performance survey was administered at the Screening/Dispensing Visit. Scores were captured on a scale from 0 to 100, with 100 being the most favorable score. Favorable responses were defined as scores of 80 or greater.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr. James Ferrari

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath